Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice

Shrikant R Mulay1, Jonathan N Eberhard1, Victoria Pfann2

  • 1Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.

Insights

Researchers developed a new mouse model for chronic kidney disease (CKD) using an oxalate-rich diet. This inducible model mimics human CKD complications, offering a valuable tool for future research into kidney disease treatments.

Area of Science:

  • Nephrology
  • Animal Models
  • Toxicology

Background:

  • Chronic kidney disease (CKD) research is hindered by the absence of practical inducible animal models that replicate human disease and its complications.
  • Existing models often fail to fully capture the complexity of CKD progression and associated pathologies.

Purpose of the Study:

  • To establish a novel, inducible mouse model for chronic kidney disease (CKD) that accurately mimics human disease characteristics and complications.
  • To validate the utility of this model for studying CKD pathogenesis and potential therapeutic interventions.

Main Methods:

  • Induction of CKD in C57BL/6 mice using a soluble oxalate-rich diet.
  • Assessment of renal histology, including tubular damage, glomerular changes, inflammation, and fibrosis.
  • Analysis of gene expression markers and magnetic resonance imaging (MRI) for inflammation and fibrosis.
  • Monitoring of physiological parameters such as anemia, metabolic acidosis, electrolyte balance, and hypertension.

Main Results:

  • The oxalate-rich diet successfully induced stable stages of CKD in both male and female mice.
  • Histological analysis revealed dose-dependent tubular damage, interstitial inflammation, fibrosis, and glomerular obsolescence.
  • Mice developed key CKD complications within 3 weeks, including anemia, metabolic acidosis, hyperkalemia, hyperphosphatemia, hyperparathyroidism, and FGF23 activation.
  • The model exhibited persistent arterial hypertension and cardiac fibrosis, even after dietary intervention.

Conclusions:

  • A novel, diet-inducible mouse model for CKD has been successfully established, closely mirroring human disease features.
  • This model overcomes limitations of previous experimental systems and provides a robust platform for investigating CKD and its multifaceted complications.
  • The model's ability to induce progressive renal and cardiovascular pathology makes it highly valuable for preclinical research and drug development in nephrology.